We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hematological Parameters Extended for Automated Analyzer

By LabMedica International staff writers
Posted on 20 Jul 2011
The quantification of the percentages of microcytic and hypochromic erythrocytes has proved clinically useful in the differential diagnosis of anemia. More...


Based on classical hematological parameters, subjects with iron deficiency anemia (IDA) are inappropriately differentiated from subjects with anemia owing to thalassemia or chronic disease.

A study conducted at the Hospital Galdakao-Usansolo, (Galdakao, Spain), aimed to establish characteristic analytical features, including the new erythrocyte and reticulocyte parameters, in case of thalassemia trait and IDA. The study population included 90 healthy individuals, 136 β-thalassemia carriers, 121 with mild IDA, and 126 with severe IDA. The scientists used the Sysmex XE 5000, which utilizes the flow fluorescence-cytometry technology, enables independent measurement of the volume and hemoglobin (Hb) content of individual red cells (RBC). Derived from this technology, four new RBCs extended parameters, erythrocyte subsets, are now reported for this analyzer.

When using the Sysmex XE 5000 analyzer, (Sysmex Corporation, Kobe, Japan; www.sysmex.com), the percentages of erythrocyte subsets can be calculated and the new parameters, such percentage of microcytic red cells (%Micro R) and percentage of macrocytic red cells (%Macro R) can be obtained. In the reticulocyte channel, blood cells are stained by a polymethine dye specific for ribonucleic acid, (RNA) /DNA, and analyzed by flow cytometry using a semiconductor laser. A bidimensional distribution of forward scattered light and fluorescence is presented as a scattergram, indicating mature red cells and reticulocytes. Forward scatter correlates with reticulocyte hemoglobin content (Ret He) and erythrocyte hemoglobin content (RBC He).

The results of the study indicate that although the differences between the three groups of anemic patients were statistically significant, the central 95th percentile ranges showed considerable overlap for most hematological parameters including absolute reticulocyte count. The values obtained for the RBC extended parameters were significantly different in the groups. The %Micro R was more increased in thalassemia (38.6 %) than in the mild IDA (16.5%), and in severe IDA (21.6%). Immature reticulocyte fraction (IRF) mean values in the groups were statistically different as the thalassemia group had an intermediate value of 8.7%, which was between the healthy value of 4.4% and IDA values ranging from 12.9% to 16.7%.

The authors concluded the erythrocytosis and severe microcytosis, together with a high percentage of microcytes and a moderate increase in IRF, is the profile of β-thalassemia carriers, whereas anisocytosis and the hypochromic subset correlates with the severity of the anemia in iron-deficient patients. The study was published online on May 12, 2011, in Journal of Clinical Laboratory Analysis.

Related Links:

Hospital Galdakao-Usansolo
Sysmex Corporation



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.